2 - DNA Methylation and Cancer
Introduction
To establish an organism, classical genetic processes are not sufficient. For proper development and cell functioning, the epigenetic phenomena are absolutely required, controlling gene expression. Epigenetic could be defined as study of heritable changes in gene expression that occur independently of changes in primary DNA sequence. Distinct epigenomes may explain differences in cell state during development when zygote transforms to somatic tissue, even if the DNA stays the same. It seems also logic that epigenetic correlates with several diseases, that has been proved in monozygotic twins that are sharing exactly the same genetic material but not necessarily the same epigenome (Fraga et al., 2005).
Epigenetic regulation of gene expression is mediated by mechanisms such as methylation of DNA, modifications of histones, and positioning of nucleosome along the DNA. The interplay between epigenetic components guarantees proper balance between transcriptional activity and repression by changing chromatin architecture. Thus, regulation of packaging of DNA ensures maintenance of correct chromosome replication, gene expression, and stable gene silencing (Esteller, 2007). DNA methylation is one of the most intensely studied epigenetic modifications in mammals and it has an important impact on normal cell physiology. As this DNA modification seems to be a critical player in the transcriptional regulation, it is not surprising that defects in this mechanism may lead to various diseases, including cancer (Esteller, 2008). Indeed, in 1983 Feinberg and Vogelstein observed reduction of DNA methylation of specific genes in human colon cancer cells, comparing with normal tissues (Feinberg and Vogelstein, 1983). In the same year, Gama-Sosa et al. described a global reduction of 5-methylcytosine content of DNA from tumor samples (Gama-Sosa et al., 1983). Since these findings, being the first proof of molecular epigenetic abnormalities in cancer, we have significantly broadened our knowledge in that field (Esteller, 2008). Even if there is still far less known about epigenetic inheritance system and mechanisms of action than traditional genetics, the importance of DNA methylation in carcinogenesis is beyond any doubt.
In this chapter, we will try to summarize our actual state of knowledge concerning DNA methylation alteration in tumor progression.
Section snippets
The Molecular Basis of DNA Methylation
The propagation of DNA methylation is well understood at the biochemical level. It consists of the covalent addition of a methyl group (–CH3) that occurs exclusively at the 5 position of the cytosine moiety (Fig. 2.1A). Intriguingly, methylated cytosine could be converted into 5-hydroxymethylcytosine (hmC), structurally similar to its unmodified counterpart (Tahiliani et al., 2009). This kind of modification was found in cerebellar Purkinje neurons and in embryonic stem cells but the biological
DNA Methylation Abnormalities in Cancer
Appropriate DNA methylation is essential for development and proper cell functioning, thus any abnormalities in this process may lead to various diseases, including cancer. Indeed, tumor cells are characterized by a different methylome from that of normal cells. Interestingly, both hypo- and hypermethylation events can be observed in cancer. Generally, a global decrease in methylated CpG content is observed. This phenomenon contributes to genomic instability and, less frequently, to activation
DNA Methylation Markers
Despite our constantly growing understanding of carcinogenesis, there is still an eager needs to design novel, powerful tools that can be applied as part of clinical practice. Tumor biomarkers are indispensable not only for early diagnosis of cancer but also for prognosis, prediction of therapeutic response, monitoring therapy, or assessment of risk of recurrence after curative surgery. Many different molecules, including nucleic acids, proteins, or even small metabolites, could be used as the
Determining the Cancer DNA Methylome
The importance of DNA methylation alterations in tumorigenesis encourages us to decode the human epigenome. Nowadays, various methods are available to assess the DNA methylation pattern of particular DNA regions. Important progress has also been made toward completing a large-scale analysis of DNA methylation.
5-Methylcytosines can be detected by three possible methods based on (1) bisulfite conversion of DNA, (2) methyl-sensitive restriction enzymes, or (3) chromatin immunoprecipitation (ChIP)
Therapy Perspectives
Unlike genetic alterations, epigenetic events, including DNA methylation, are reversible, which makes it extremely interesting from the point of view of developing new approaches to therapy. The agents capable of restoring the normal cell DNA methylation pattern have been developed in the course of several studies. The strategies use special drugs to inactivate DNMTs. As an expected result of this approach, DNMT inhibitors should trigger the loss of the overall level that is thought to randomly
Conclusions
Since its discovery, DNA methylation has captured a lot of interest and its fundamental role in proper cell functioning is broadly recognized. Numerous studies have shown the key role of DNA methylation in tumor development and progression. Particularly, promoter hypermethylation resulting in gene silencing is one of the central players in cancer. In addition to classical genetic abnormalities, DNA methylation aberrations are considered as a second layer of tumorigenesis complexicity. Moreover,
References (118)
- et al.
DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells
Gynecol. Oncol.
(2001) Inhibition of DNA methylation by antisense oligonucleotide MG98 as cancer therapy
Clin. Genitourin. Cancer
(2007)- et al.
A brief review on the mechanisms of miRNA regulation
Genomics Proteomics Bioinformatics
(2009) - et al.
BRCA1 methylation: A significant role in tumour development?
Semin. Cancer Biol.
(2002) - et al.
Kinetics of deamination of 5-aza-2′-deoxycytidine and cytosine arabinoside by human liver cytidine deaminase and its inhibition by 3-deazauridine, thymidine or uracil arabinoside
Biochem. Pharmacol.
(1983) - et al.
Role of DNA hypomethylation in the development of the resistance to doxorubicin in human MCF-7 breast adenocarcinoma cells
Cancer Lett.
(2006) - et al.
Preferential response of cancer cells to zebularine
Cancer Cell
(2004) - et al.
SATR-1 hypomethylation is a common and early event in breast cancer
Cancer Genet. Cytogenet.
(2006) - et al.
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach
Cancer Cell
(2004) - et al.
MGMT hypermethylation: A prognostic foe, a predictive friend
DNA Repair (Amst.)
(2007)
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Cell
Alteration of DNA methyltransferases contributes to 5′CpG methylation and poor prognosis in lung cancer
Lung Cancer
Epigenetic biomarkers for human cancer: The time is now
Crit. Rev. Oncol. Hematol.
DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development
Cell
A unifying model for the selective regulation of inducible transcription by CpG islands and nucleosome remodeling
Cell
CTCF is a DNA methylation-sensitive positive regulator of the INK/ARF locus
Biochem. Biophys. Res. Commun.
Restriction landmark genomic scanning for DNA methylation in cancer: Past, present, and future applications
Anal. Biochem.
Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells
Cancer Cell
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
Clin. Biochem.
Roles of the EZH2 histone methyltransferase in cancer epigenetics
Mutat. Res.
GATA-4 and GATA-5 transcription factor genes and potential downstream antitumor target genes are epigenetically silenced in colorectal and gastric cancer
Mol. Cell. Biol.
CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: Genomic hypomethylation correlates with carcinogenic progression
J. Virol.
Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs
Oncogene
Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer
EMBO J.
A novel technique for the identification of CpG islands exhibiting altered methylation patterns (ICEAMP)
Nucleic Acids Res.
Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases
Cancer Res.
Cancer/testis (CT) antigens: Potential targets for immunotherapy
Cancer Sci.
Substrate connectivity effects in the transition state for cytidine deaminase
Biochemistry
The DNA methyltransferase-like protein DNMT3L stimulates de novo methylation by Dnmt3a
Proc. Natl. Acad. Sci. USA
Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene
J. Natl. Cancer Inst.
Translating insights from the cancer genome into clinical practice
Nature
5-Azacytidine and 5-aza-2′-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy
Oncogene
The p120(ctn)-binding partner Kaiso is a bi-modal DNA-binding protein that recognizes both a sequence-specific consensus and methylated CpG dinucleotides
Nucleic Acids Res.
A new class of quinoline-based DNA hypomethylating agents reactivates tumor suppressor genes by blocking DNA methyltransferase 1 activity and inducing its degradation
Cancer Res.
MicroRNAs and cancer epigenetics: A macrorevolution
Curr. Opin. Oncol.
Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling
Arthritis Rheum.
Dnmt3L is a transcriptional repressor that recruits histone deacetylase
Nucleic Acids Res.
Relationship of SNCG, S100A4, S100A9 and LCN2 gene expression and DNA methylation in bladder cancer
Int. J. Cancer
Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells
Leukemia
MethyLight: A high-throughput assay to measure DNA methylation
Nucleic Acids Res.
The necessity of a human epigenome project
Carcinogenesis
Cancer epigenomics: DNA methylomes and histone-modification maps
Nat. Rev. Genet.
Epigenetics in cancer
N. Engl. J. Med.
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
Cancer Res.
Hypermethylation-associated inactivation of the cellular retinol-binding-protein 1 gene in human cancer
Cancer Res.
Hypomethylation distinguishes genes of some human cancers from their normal counterparts
Nature
The epigenetic progenitor origin of human cancer
Nat. Rev. Genet.
A family of human zinc finger proteins that bind methylated DNA and repress transcription
Mol. Cell. Biol.
Hypermethylation of the hMLH1 gene promoter is associated with microsatellite instability in early human gastric neoplasia
Oncogene
Epigenetic differences arise during the lifetime of monozygotic twins
Proc. Natl. Acad. Sci. USA
Cited by (1181)
Natural bioactive compounds targeting DNA methyltransferase enzymes in cancer: Mechanisms insights and efficiencies
2024, Chemico-Biological InteractionsRegucalcin downregulation in human cancer
2024, Life SciencesBeyond genetics: Exploring the role of epigenetic alterations in breast cancer
2024, Pathology Research and Practice